0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Large Trial Finds Ticlopidine Superior to Aspirin in Preventing Stroke

Beverly Merz
JAMA. 1989;261(11):1541. doi:10.1001/jama.1989.03420110015001.
Text Size: A A A
Published online

ABSTRACT

IT'S A NEW CHEMICAL entity, and no one is sure exactly how it works, but ticlopidine hydrochloride appears to work better than aspirin in staving off stroke in high-risk patients, according to the results of a 55-center trial.

That was the word from William K. Hass, MD, one of the principal investigators of the Ticlopidine/Aspirin Stroke Study. Hass summarized the study's results at the recent 14th International Joint Conference on Stroke and Cerebral Circulation in San Antonio, Tex.

Hass, professor of neurology at New York (NY) University School of Medicine, told the conference that the drug, developed by Syntex Corporation, Palo Alto, Calif, was superior to aspirin in preventing both fatal and nonfatal strokes. He said that the side effects were minor and reversible.

The study undertaken in 1981 involved 3069 patients who had suffered a transient ischemic attack or a more prolonged, but reversible, ischemic deficit within the 90

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();